Thermo Fisher Scientific (TMO) Competitors $478.60 +3.58 (+0.75%) Closing price 03:59 PM EasternExtended Trading$474.00 -4.61 (-0.96%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WATShould you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector. Thermo Fisher Scientific vs. Its Competitors Medpace Agilent Technologies AMN Healthcare Services Danaher Haemonetics McKesson Qiagen West Pharmaceutical Services Mettler-Toledo International Waters Thermo Fisher Scientific (NYSE:TMO) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk. Do analysts recommend TMO or MEDP? Thermo Fisher Scientific presently has a consensus target price of $593.00, suggesting a potential upside of 23.90%. Medpace has a consensus target price of $411.10, suggesting a potential downside of 8.13%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, equities research analysts plainly believe Thermo Fisher Scientific is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 5 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.75Medpace 2 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, TMO or MEDP? Thermo Fisher Scientific has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Is TMO or MEDP more profitable? Medpace has a net margin of 18.74% compared to Thermo Fisher Scientific's net margin of 15.24%. Medpace's return on equity of 67.66% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.24% 16.82% 8.38% Medpace 18.74%67.66%21.86% Do insiders and institutionals believe in TMO or MEDP? 89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by company insiders. Comparatively, 20.3% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer TMO or MEDP? In the previous week, Thermo Fisher Scientific had 52 more articles in the media than Medpace. MarketBeat recorded 92 mentions for Thermo Fisher Scientific and 40 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 0.92 beat Medpace's score of 0.76 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 49 Very Positive mention(s) 16 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 12 Very Positive mention(s) 8 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, TMO or MEDP? Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$42.88B4.21$6.34B$17.0528.07Medpace$2.23B5.76$404.39M$13.4533.27 SummaryThermo Fisher Scientific beats Medpace on 9 of the 16 factors compared between the two stocks. Get Thermo Fisher Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMO vs. The Competition Export to ExcelMetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$180.67B$7.00B$5.74B$21.13BDividend Yield0.37%1.28%4.60%3.58%P/E Ratio27.6825.5128.1127.87Price / Sales4.2166.31461.3759.63Price / Cash15.5420.6736.5523.02Price / Book3.584.758.654.69Net Income$6.34B$176.14M$3.25B$995.51M7 Day Performance15.25%2.92%4.20%1.64%1 Month Performance16.61%3.56%10.82%5.92%1 Year Performance-19.49%7.66%34.70%11.50% Thermo Fisher Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMOThermo Fisher Scientific4.9533 of 5 stars$478.61+0.8%$593.00+23.9%-17.3%$180.67B$42.88B27.68125,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionMEDPMedpace3.7039 of 5 stars$310.14-0.6%$344.82+11.2%+19.3%$8.92B$2.11B23.695,900Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownAAgilent Technologies4.7471 of 5 stars$112.86-1.0%$139.77+23.8%-10.3%$32.08B$6.51B27.8817,900Positive NewsAMNAMN Healthcare Services4.2089 of 5 stars$18.45-6.9%$32.08+73.9%-68.2%$710.86M$2.98B-4.292,968DHRDanaher4.8284 of 5 stars$189.18-0.5%$248.48+31.3%-23.5%$135.50B$23.88B36.7663,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHAEHaemonetics4.9308 of 5 stars$74.10+2.1%$97.30+31.3%-18.9%$3.56B$1.36B22.393,023Positive NewsMCKMcKesson4.6048 of 5 stars$711.34+0.2%$710.17-0.2%+20.4%$89.04B$359.05B27.5545,000Positive NewsQGENQiagen3.7097 of 5 stars$48.21-0.3%$49.40+2.5%+25.6%$10.73B$1.98B120.975,765Positive NewsAnalyst RevisionWSTWest Pharmaceutical Services4.4708 of 5 stars$210.97+0.0%$320.00+51.7%-13.9%$15.16B$2.89B33.1310,600Trending NewsEarnings ReportDividend IncreaseAnalyst ForecastMTDMettler-Toledo International4.1324 of 5 stars$1,173.27-1.8%$1,280.90+9.2%-8.8%$24.41B$3.87B29.2917,300Positive NewsUpcoming EarningsWATWaters4.8358 of 5 stars$282.77-1.7%$381.94+35.1%-2.3%$16.85B$2.96B25.697,600Trending NewsHigh Trading Volume Related Companies and Tools Related Companies Medpace Alternatives Agilent Technologies Alternatives AMN Healthcare Services Alternatives Danaher Alternatives Haemonetics Alternatives McKesson Alternatives Qiagen Alternatives West Pharmaceutical Services Alternatives Mettler-Toledo International Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMO) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMO Stock Alerts